Ms. Barragán (for herself and Mr. Joyce of Pennsylvania) introduced the following bill; which was referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
To amend title XVIII of the Social Security Act to provide a review process for adverse national coverage determinations with respect to drug coverage under the Medicare program.
Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. House. Access to Innovative Treatments Act of 2026. H.R. 9418. 119th
Cong., 2nd
sess., Introduced in House June 24, 2026. https://www.govinfo.gov/app/details/BILLS-119hr9418ih.
APA
Congress, House of Representatives (2026, June 24). Access to Innovative Treatments Act of 2026 (H.R. 9418 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119hr9418ih.
MLA
United States, Congress, House of Representatives. Access to Innovative Treatments Act of 2026. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119hr9418ih. 119th Congress, H.R. 9418, Introduced in House 24 Jun. 2026.
Bluebook
H.R.9418 - 119th Congress (2025-2026): Access to Innovative Treatments Act of 2026, H.R.9418, 119th Cong. (2026), https://www.govinfo.gov/app/details/BILLS-119hr9418ih.
